Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.58 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.36 |
| ▸ | TGM2 | P21980 | 6/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CBLB | Q13191 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2803754 | 0.98 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2GAATSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL475933 | 0.96 | ZDHHC20 (0.58) | ZDHHC20ZDHHC2GAATSHRALDH1A1 | |
| Bromide SCHEMBL30032600 | 0.95 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2GAATSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL30033466 | 0.91 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2GAATSHRALDH1A1 | |
| Acrylic Acid SCHEMBL5023742 | 0.90 | ZDHHC20 (0.51) | ZDHHC20ZDHHC2GAATSHRALDH1A1 | |
| Bromide SCHEMBL30033465 | 0.89 | ZDHHC20 (0.52) | ZDHHC20ZDHHC2GAATSHRALDH1A1 | |
| Bromide SCHEMBL9771616 | 0.88 | ZDHHC20 (0.71) | ZDHHC20ZDHHC2GAATSHRALDH1A1 | |
| SCHEMBL1200572 | 0.87 | ZDHHC20 (0.53) | ZDHHC20ZDHHC2GAATSHRALDH1A1 | |
| SCHEMBL28417958 | 0.86 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2GAATSHRALDH1A1 | |
| Iodide SCHEMBL29129904 | 0.85 | ZDHHC20 (0.52) | ZDHHC20ZDHHC2GAATSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570860-B2 | Two-component treatment agent, treatment method for making metal surface antibacterial and antibacterial treatment agent | TOKYO OHKA KOGYO CO., LTD. (JP) | 2026-03-10 | — | — | US | disclosed |
| US-20220267615-A1 | TWO-COMPONENT TREATMENT AGENT, TREATMENT METHOD FOR MAKING METAL SURFACE ANTIBACTERIAL AND ANTIBACTERIAL TREATMENT AGENT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2022-08-25 | — | — | US | disclosed |
| US-8722824-B2 | Relative permeability modifiers based on hydrophobically modified cationic copolymers | ENI S.P.A. (IT) | 2014-05-13 | — | — | US | disclosed |
| US-20120130037-A1 | RELATIVE PERMEABILITY MODIFIERS BASED ON HYDROPHOBICALLY MODIFIED CATIONIC COPOLYMERS | ENI S.P.A. (IT) | 2012-05-24 | — | — | US | disclosed |
| US-7923083-B2 | Recording medium, ink composition and recording method using the same | FUJIFILM CORPORATION (JP) | 2011-04-12 | — | — | US | disclosed |
| EP-1621359-B1 | Recording medium and its method of manufacture | FUJIFILM CORP (JP) | 2008-01-02 | — | — | EP | disclosed |
| EP-1621359-A2 | Recording medium, ink composition and recording method using the same | FUJI PHOTO FILM CO., LTD. (JP) | 2006-02-01 | — | — | EP | disclosed |
| US-20050233097-A1 | Recording medium, ink composition and recording method using the same | FUJI PHOTO FILM CO., LTD. | 2005-10-20 | — | — | US | disclosed |
| WO-2005087499-A1 | RECORDING MEDIUM, INK COMPOSITION AND RECORDING METHOD USING THE SAME | FUJI PHOTO FILM CO., LTD. (JP) | 2005-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570860-B2 | Two-component treatment agent, treatment method for making metal surface antibacterial and antibacterial treatment agent | SARS1, ACE2, EIF2AK2 | ZDHHC20 1582/4885ZDHHC2 1068/4885GAA 1691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.